Mannkind Corporation (MNKD)
NASDAQ · Manufacturing · Pharmaceutical preparations
$3.36+$0.0677 (+2.06%) on the dayAs of the close; data may be delayed.
MNKD price, last 12 months
Key stats
- Previous close
- $3.29
- Open
- $3.29
- Day range
- $3.17 – $3.39
- 52-week range
- $2.23 – $6.51
- Volume
- 8.3M
- Avg volume (20 days)
- 4.1M
- Market cap
- $1.1B
Performance
1W−5.2%
1M−17.9%
3M−18.9%
6M+46.0%
YTD−40.8%
1Y−37.0%
vs S&P 500, 1Y−53.8 pts
Technicals and fundamentals
About Mannkind Corporation
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.1B